Press Room

DDF - Global Drug Delivery & Formulation Summit 2025

Start
Monday, June 02, 2025 - 09:00
End
Wednesday, June 04, 2025 - 18:00
Location: Berlin, Germany
Booth Number: Table #16
Synthetic Sugars | Hovione

Hovione is exhibiting at DDF Berlin, a leading 3-day summit on drug delivery, formulation and device development that attracts over 400 senior pharmaceutical leaders. At this event, top-notch experts engage in discussions on the latest advancements in the industry, presenting case studies and sharing invaluable experience.

 

Do not miss our Solution Spotlight Session, on June 2 (Room 4, 10:00 - 10:30 am):

“Next generation of Excipients for Proteins: enhancing stability and reducing viscosity”  

The pharmaceutical industry continues to push the boundaries of innovation, particularly in the field of biologics, which now represents a significant and growing segment of therapeutic development. As these complex molecules become more prevalent, addressing formulation challenges such as stability and high viscosity becomes increasingly critical. Traditional excipients often fall short in meeting the unique demands of modern biologics, prompting the need for next-generation solutions. 

Novel excipients offer a promising path forward, enabling enhanced protein stability, reduced viscosity, and improved manufacturability and delivery. With regulatory frameworks beginning to recognize the importance of excipient innovation, now is a pivotal moment for industry stakeholders to explore and implement these advancements in protein therapeutics development. 

In our Solution Spotlight Session, presented by Joana Cristovão – R&D Manager – we introduce a platform of novel synthetic sugars designed to ensure more robust biopharmaceuticals. Case studies demonstrate the significant improvements these sugars provide in enhancing model proteins manufacturing processes, stability, and viscosity reduction across various applications.

Session Highlights:

  • Tackling complexity in protein therapeutics: Addressing the limitations of traditional formulations for high-concentration and complex biologics.
  • Next-gen excipients in action: Real-world data showing improved stability and manufacturability using novel excipients.

     

Speak with our experts and learn how our extensive knowledge and experience can support your project from early stages of development to commercialization.

We look forward to seeing you at DDF Berlin.

Schedule a meeting today.

 

schedule a meeting

 

 

 

 

 

 

Also in the Press Room

See All

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026